Novel Syk inhibitors with high potency in presence of blood

We describe two series of Syk inhibitors which potently abrogate Syk kinase function in enzymatic, cellular assays and in primary cells in the presence of blood. Introduction of a 7-aminoindole substituent led to derivatives with good kinase selectivity and little or no hERG channel inhibition (3b, 10c).